Evotec to Acquire Aptuit for $300 Million
Evotec, a Hamburg, Germany-based drug discovery and development company, has agreed to acquire Aptuit, a Greenwich, Connecticut-based pharmaceutical services company, for $300 million.
Aptuit offers preclinical testing as well as drug-substance and drug-product manufacturing. Aptuit has manufacturing facilities in Europe (Verona, Italy; Basel, Switzerland; and Oxford, UK). It has approximately 750 employees. It had 2016 revenues of approximately EUR 88 million ($104 million).
The acquisition is expected to close in the third quarter of 2017.
